文献速递骨质疏松与代谢性骨病创伤骨科

亚临床甲状腺功能亢进与老年男性椎体骨折风险增加相关

Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.
PubMed 文献 · Osteoporos Int · 2021-05-19

在MrOS-Sweden研究的瑞典老年男性队列中,亚临床甲状腺功能亢进(SHyper)与椎体骨折风险显著增加相关(HR 3.79,95%CI 2.02-7.11),与全部骨折和主要骨质疏松性骨折的关联在排除左甲状腺素治疗者后失去显著性。

要点

  • SHyper与椎体骨折风险增加独立相关,校正骨密度后仍显著。
  • SHyper与全部骨折和主要骨质疏松性骨折的关联需进一步研究确认。
  • 排除左甲状腺素治疗者后,全部骨折和主要骨质疏松性骨折的关联失去显著性。

核心结论

  • 在瑞典老年男性中,SHyper与椎体骨折风险增加强烈相关,而与全部骨折和主要骨质疏松性骨折的关联需进一步研究确认。

研究设计与样本

  • 前瞻性、基于人群的MrOS-Sweden研究,纳入哥德堡和马尔默两个亚队列的1856名老年男性(平均年龄75岁,范围69-81岁),中位随访9.8年,采用Cox比例风险回归分析。

主要发现

  • SHyper与全部骨折风险增加相关(n=456;校正年龄、研究中心和左甲状腺素治疗后的HR=1.99,95%CI 1.20-3.32)。
  • SHyper与主要骨质疏松性骨折风险增加相关(n=338;HR=2.44,95%CI 1.42-4.21)。
  • SHyper与椎体骨折风险增加相关(n=176;HR=3.79,95%CI 2.02-7.11)。
  • 上述关联在全面校正包括全髋骨密度在内的协变量后仍存在,在仅纳入血清游离甲状腺素≤正常上限的男性亚组分析中亦如此。
  • 排除接受左甲状腺素治疗的男性后,与全部骨折和主要骨质疏松性骨折的关联失去显著性。

关键数值与推荐

  • SHyper定义为血清促甲状腺激素(TSH)< 0.45 mIU/L(n=38)。

临床怎么用

  • 对老年男性,需关注亚临床甲状腺功能亢进状态以评估椎体骨折风险。
  • 甲状腺功能评估可能有助于识别椎体骨折高危的老年男性。

局限性

  • SHyper组样本量较小(n=38)。
  • 排除左甲状腺素治疗者后全部骨折和主要骨质疏松性骨折的关联失去显著性,需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: In elderly men included in MrOS-Sweden, subclinical hyperthyroidism (SHyper) was markedly associated with increased risk of vertebral fractures. INTRODUCTION: Overt hyperthyroidism is associated with increased risk of fractures. However, only a few studies have investigated whether SHyper is associated with fracture risk in elderly men. We therefore investigated if SHyper was a risk factor for fractures in Swedish men. METHODS: We followed (median 9.8 years) elderly men (n = 1856; mean age 75, range 69-81 years) participating in the Gothenburg and Malmö subcohorts of the prospective, population-based MrOS-Sweden study. The statistical analyses included Cox proportional hazards regression. SHyper was defined as serum thyroid-stimulating hormone (TSH) < 0.45 mIU/L (n = 38). RESULTS: SHyper was associated with increased risk of all fractures [n = 456; hazard ratio (HR) adjusted for age, study center, and levothyroxine treatment = 1.99, 95% confidence interval (CI): 1.20-3.32], major osteoporotic fractures (MOF, n = 338; HR 2.44, 95% CI: 1.42-4.21), and vertebral fractures (n = 176; HR 3.79, 95% CI: 2.02-7.11). These associations remained after full adjustment for covariates including total hip bone mineral density and in subanalyses including only men with serum free thyroxine ≤ the upper normal limit. However, after exclusion of men receiving levothyroxine treatment, the associations with all fractures and MOF lost significance. CONCLUSIONS: In elderly Swedish men, there was a strong association between SHyper and increased risk of vertebral fractures, whereas the associations with all incident fractures and MOF need to be confirmed in further studies.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Svensson J, Ohlsson C, Karlsson MK, et al. Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men. Osteoporos Int. 2021. PMID: 34013460. doi:10.1007/s00198-021-05964-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。